Patents by Inventor Janet L. Rideout

Janet L. Rideout has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of human viral infections
    Patent number: 4724232
    Abstract: Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.
    Type: Grant
    Filed: September 17, 1985
    Date of Patent: February 9, 1988
    Assignee: Burroughs Wellcome Co.
    Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrman, Martha H. St. Clair, Phillip A. Furman
  • Anti-inflammatory deoxyribosides
    Patent number: 4481197
    Abstract: The novel compounds 3-deaza-2'-deoxyadenosine and certain of its derivatives and their pharmaceutically acceptable salts have anti-inflammatory activity as well as immune response suppression activity. 3-Deaza-2'-deoxyadenosine and certain of its intermediates are synthesized by the enzyme catalyzed reaction of the appropriately substituted 3-deazapurine with a 2'-deoxyribose donor.
    Type: Grant
    Filed: June 17, 1982
    Date of Patent: November 6, 1984
    Assignee: Burroughs Wellcome Co.
    Inventors: Janet L. Rideout, Thomas A. Krenitsky
  • Process for producing deoxyribosides using bacterial phosphorylase
    Patent number: 4381344
    Abstract: The novel compounds 3-deaza-2'-deoxyadenosine and certain of its derivatives and their pharmaceutically acceptable salts have anti-inflammatory activity as well as immune response suppression activity. 3-Deaza-2'-deoxyadenosine and certain of its intermediates are synthesized by the enzyme catalyzed reaction of the appropriately substituted 3-deazapurine with a 2'-deoxyribose donor.
    Type: Grant
    Filed: April 25, 1980
    Date of Patent: April 26, 1983
    Assignee: Burroughs Wellcome Co.
    Inventors: Janet L. Rideout, Thomas A. Krenitsky
  • Synthesis of ribosides using bacterial phosphorylase
    Patent number: 4347315
    Abstract: 4-Substituted-3-deazapurine ribosides are prepared by the enzymatically catalyzed reaction of 4-substituted-3-deazapurine with a ribose donor.
    Type: Grant
    Filed: April 25, 1980
    Date of Patent: August 31, 1982
    Assignee: Burroughs Wellcome Co.
    Inventors: Thomas A. Krenitsky, Janet L. Rideout
  • Pyrazolo pyrimidine riboside compounds, pharmaceutical compositions and method of use
    Patent number: 4299823
    Abstract: 4-Substituted alkyl-1-.alpha.-D-ribofuransylpyrazole-(3,4-d) pyrimidines are active against coccidia in vivo and unlike the 4-methylthio analogue, are non-toxic. Methods for preparing and using the compounds, intermediates in the preparation and compositions of the compounds are also described.
    Type: Grant
    Filed: June 13, 1980
    Date of Patent: November 10, 1981
    Assignee: Burroughs Wellcome Co.
    Inventors: Janet L. Rideout, Thomas A. Krenitsky, Gertrude B. Elion
  • Substituted pyrazolo pyrimidine riboside compounds, pharmaceutical compositions and method of use
    Patent number: 4299824
    Abstract: 4-Alkenylthio-1-.beta.-D-ribofuranosylpyrazolo[3,4-d]-pyrimidines are active against coccidia in vivo, and unlike the 4-methylthio analogue, are non-toxic. Methods for the preparation and use of the compounds, intermediates in the preparation and formulations of the compounds are also described.
    Type: Grant
    Filed: June 13, 1980
    Date of Patent: November 10, 1981
    Assignee: Burroughs Wellcome Co.
    Inventors: Janet L. Rideout, Thomas A. Krenitsky, Gertrude B. Elion